# BLVRB

## Overview
Biliverdin reductase B (BLVRB) is a gene that encodes the enzyme biliverdin IXβ reductase, a member of the short-chain dehydrogenases/reductases (SDR) family. This enzyme plays a pivotal role in the heme degradation pathway by catalyzing the reduction of biliverdin isomers to bilirubin, utilizing NAD(P)H as a cofactor. Biliverdin reductase B is crucial for maintaining cellular redox homeostasis and antioxidant defense, impacting various physiological processes such as oxidative stress response and cellular signaling (Wu2016BLVRB; Chu2017Enzymatic). The enzyme's structure is characterized by a Rossmann fold, which facilitates its interaction with dinucleotides like NADPH, and it undergoes conformational changes during its catalytic cycle (Bahou2023Metabolic; Lee2023Identifying). BLVRB's activity is significant in bioenergetic metabolism and is implicated in several clinical conditions, including thrombocytosis and cancer, highlighting its potential as a therapeutic target (Bahou2023Metabolic; Gao2022Biliverdin).

## Structure
Biliverdin reductase B (BLVRB) is an enzyme with a primary structure consisting of a sequence of amino acids that form a typical short-chain dehydrogenases/reductases (SDR) fold. This fold includes a central β-sheet flanked by α-helices, which is characteristic of nucleotide-binding proteins (Lee2023Identifying). The enzyme's tertiary structure is compact and globular, featuring a Rossmann fold, which is common in proteins that bind dinucleotides like NADPH and NADH (Bahou2023Metabolic).

BLVRB has a single dinucleotide binding domain that accommodates cofactors, with a preference for NADPH over NADH. Key residues such as Arg35, Arg78, and Thr12 are involved in the binding of NADPH, with Arg35 playing a critical role in the enzyme's preference for this cofactor (Bahou2023Metabolic). The enzyme undergoes significant conformational changes during its catalytic cycle, particularly involving the R78-loop, which becomes ordered upon coenzyme binding (Lee2023Identifying).

BLVRB can exist in different isoforms due to alternative splicing, and it may undergo post-translational modifications such as phosphorylation. These structural features and modifications are crucial for its function in cellular redox regulation and heme metabolism (Duff2020Structure).

## Function
The BLVRB gene encodes biliverdin IXβ reductase, an enzyme crucial in the heme degradation pathway. It catalyzes the NAD(P)H-dependent reduction of biliverdin isomers to bilirubin, a potent antioxidant, thereby playing a significant role in cellular antioxidant defense and redox homeostasis (Wu2016BLVRB; Chu2017Enzymatic). This enzymatic activity is essential for neutralizing reactive oxygen species (ROS), which are critical signaling molecules in various cellular processes, including megakaryocyte differentiation and stem cell quiescence (Wu2016BLVRB).

BLVRB is active in the cytoplasm and is involved in maintaining cellular redox balance, impacting processes like oxidative stress response and cellular signaling (Li2018Heme). It also plays a role in the bioenergetic metabolism of pluripotent stem cells by regulating glutamine metabolism, which is crucial for maintaining cellular viability and differentiation potential (Li2018Heme). The enzyme's activity is linked to the regulation of metabolic pathways, including the pentose phosphate pathway, which supports nucleotide biosynthesis and redox homeostasis (Li2018Heme).

In healthy human cells, BLVRB's function extends beyond heme metabolism, contributing to bioenergetic metabolism and antioxidant functions, which are vital for maintaining cellular homeostasis and organismal health (Chu2017Enzymatic).

## Clinical Significance
Mutations and alterations in the BLVRB gene have been linked to several clinical conditions, particularly those involving platelet production and cancer. The BLVRB S111L mutation is a significant risk factor for thrombocytosis, a condition characterized by elevated platelet counts. This mutation is associated with both essential thrombocythemia (ET) and reactive thrombocytosis (RT), affecting the gene's redox activity and leading to defective handling of reactive oxygen species (ROS) (Wu2016BLVRB; Bahou2023Metabolic). The mutation results in increased megakaryocyte proliferation and exaggerated thrombocytosis, impacting erythroid and megakaryocyte development (Wu2016BLVRB; Bahou2023Metabolic).

In cancer, BLVRB expression is implicated in various malignancies. In cholangiocarcinoma (CCA), low BLVRB expression is linked to poor prognosis and increased cell motility, suggesting a role in cancer progression through the Notch/Snail signaling pathway (Gao2022Biliverdin). Additionally, BLVRB is overexpressed in several cancers, including breast and prostate cancer, where it is associated with tumor progression and metastasis (Bahou2023Metabolic). These findings highlight BLVRB's potential as a therapeutic target in both hematological disorders and cancer.


## References


[1. (Chu2017Enzymatic) Wen‐Ting Chu, Natasha M. Nesbitt, Dmitri V. Gnatenko, Zongdong Li, Beibei Zhang, Markus A. Seeliger, Seamus Browne, Timothy J. Mantle, Wadie F. Bahou, and Jin Wang. Enzymatic activity and thermodynamic stability of biliverdin ixβ reductase are maintained by an active site serine. Chemistry – A European Journal, 23(8):1891–1900, January 2017. URL: http://dx.doi.org/10.1002/chem.201604517, doi:10.1002/chem.201604517. This article has 12 citations.](https://doi.org/10.1002/chem.201604517)

[2. (Lee2023Identifying) Eunjeong Lee, Matthew J. McLeod, Jasmina S. Redzic, Barbara Marcolin, Robert E. Thorne, Pratul Agarwal, and Elan Zohar Eisenmesser. Identifying structural and dynamic changes during the biliverdin reductase b catalytic cycle. Frontiers in Molecular Biosciences, August 2023. URL: http://dx.doi.org/10.3389/fmolb.2023.1244587, doi:10.3389/fmolb.2023.1244587. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2023.1244587)

[3. (Li2018Heme) Zongdong Li, Natasha M. Nesbitt, Lisa E. Malone, Dimitri V. Gnatenko, Song Wu, Daifeng Wang, Wei Zhu, Geoffrey D. Girnun, and Wadie F. Bahou. Heme degradation enzyme biliverdin ixβ reductase is required for stem cell glutamine metabolism. Biochemical Journal, 475(6):1211–1223, March 2018. URL: http://dx.doi.org/10.1042/bcj20180016, doi:10.1042/bcj20180016. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bcj20180016)

[4. (Wu2016BLVRB) Song Wu, Zongdong Li, Dmitri V. Gnatenko, Beibei Zhang, Lu Zhao, Lisa E. Malone, Nedialka Markova, Timothy J. Mantle, Natasha M. Nesbitt, and Wadie F. Bahou. Blvrb redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans. Blood, 128(5):699–709, August 2016. URL: http://dx.doi.org/10.1182/blood-2016-02-696997, doi:10.1182/blood-2016-02-696997. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2016-02-696997)

[5. (Bahou2023Metabolic) Wadie F. Bahou, Natalia Marchenko, and Natasha M. Nesbitt. Metabolic functions of biliverdin ixβ reductase in redox-regulated hematopoietic cell fate. Antioxidants, 12(5):1058, May 2023. URL: http://dx.doi.org/10.3390/antiox12051058, doi:10.3390/antiox12051058. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/antiox12051058)

[6. (Gao2022Biliverdin) Zhihui Gao, Xiaojian Ni, Bohao Zheng, Wentao Sun, Wenze Wan, Han Liu, Xiaoling Ni, Tao Suo, Na Li, Houbao Liu, and Sheng Shen. Biliverdin reductase b impairs cholangiocarcinoma cell motility by inhibiting the notch/snail signaling pathway. Journal of Cancer, 13(7):2159–2170, 2022. URL: http://dx.doi.org/10.7150/jca.70323, doi:10.7150/jca.70323. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.70323)

[7. (Duff2020Structure) Michael R Duff, Jasmina S Redzic, Lucas P Ryan, Natasia Paukovich, Rui Zhao, Jay C Nix, Todd M Pitts, Pratul Agarwal, and Elan Zohar Eisenmesser. Structure, dynamics and function of the evolutionarily changing biliverdin reductase b family. The Journal of Biochemistry, 168(2):191–202, April 2020. URL: http://dx.doi.org/10.1093/jb/mvaa039, doi:10.1093/jb/mvaa039. This article has 7 citations.](https://doi.org/10.1093/jb/mvaa039)